Supplemental_Table_1 – Supplemental material for Targeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma

Supplemental material, Supplemental_Table_1 for Targeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma by Zhimin Tong, Alicia Mejia, Omkara Veeranki, Anuj Verma, Arlene M. Correa, Rashmi Dokey, Viren Patel, Luisa Maren Solis, Barbara Mino, Riham Kathkuda, Jaime Rodriguez-Canales, Steven H. Lin, Sunil Krishnan, Scott Kopetz, Mariela Blum, Jaffer A. Ajani, Wayne L. Hofstetter and Dipen M. Maru in Therapeutic Advances in Medical Oncology